R. Tyler McCabe


J3 Bioscience, Inc.

For 30 years Dr. McCabe has engaged in device, pharmaceutical, and molecular diagnostic businesses. He has served on Boards and assembled several Boards for companies with whom he was affiliated. He is presently CEO and primary development lead for J3 Bioscience, a woman’s health products company. His expertise includes advancing products from discovery through clinical trials and regulatory clearance. Dr. McCabe received his PhD in pharmacology/toxicology and was awarded a post-doctoral fellowship at the NIH.